- Home
- PINE vs LENZ Comparison
PINE vs LENZ Comparison
Compare PINE & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PINE | LENZ |
|---|---|---|
| Founded | 2019 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medicinal Chemicals and Botanical Products |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 277.5M | 278.4M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PINE | LENZ |
|---|---|---|
| Price | $19.18 | $7.54 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $20.10 | ★ $44.00 |
| AVG Volume (30 Days) | 161.3K | ★ 850.9K |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 6.29% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $60,532,000.00 | $19,088,000.00 |
| Revenue This Year | $18.63 | $50.42 |
| Revenue Next Year | N/A | $197.16 |
| P/E Ratio | $321.83 | ★ N/A |
| Revenue Growth | ★ 15.90 | N/A |
| 52 Week Low | $13.10 | $6.61 |
| 52 Week High | $20.80 | $50.19 |
Technical Indicators
Market Signals| Indicator | PINE | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 48.74 | 40.53 |
| Support Level | $18.72 | $6.61 |
| Resistance Level | $19.98 | $10.42 |
| Average True Range (ATR) | 0.37 | 0.63 |
| MACD | 0.01 | 0.07 |
| Stochastic Oscillator | 42.79 | 48.67 |
Price Performance
Historical ComparisonAbout PINE Alpine Income Property Trust Inc.
Alpine Income Property Trust Inc is a real estate investment trust (REIT) that owns and operates a high-quality portfolio of commercial net lease properties in the United States. The company's portfolio predominantly comprises single-tenant retail properties located in or near metropolitan statistical areas, or MSAs. It operates in two business segments: income properties, which derive maximum revenue, and commercial loans and investments.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.